Expand TLSA Menu
TLSA MENU

TLSA Latest Press Releases

-- December 15, 2025 --

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer Globe Newswire 3:07 PM
Tiziana Life Sciences Announces Withdrawal of Proposed Public Offering Globe Newswire 7:30 AM

-- December 12, 2025 --

Tiziana Life Sciences to Dose First Patient in Phase 2 Alzheimer's Trial Globe Newswire 2:10 PM

-- December 2, 2025 --

Tiziana Life Sciences Plans to Spinout IL-6 Asset into Separate Listed Company Globe Newswire 7:00 AM

-- November 25, 2025 --

Tiziana Life Sciences Nasal Foralumab Phase 2 Clinical Trial Accepted into Healey ALS MyMatch Program Globe Newswire 8:30 AM

-- November 13, 2025 --

Tiziana Life Sciences to Present at Jefferies Global Healthcare Conference Globe Newswire 8:30 AM

-- November 4, 2025 --

Aquestive Therapeutics Announces Leadership Expansion to Support Growth Globe Newswire 7:00 AM

-- October 29, 2025 --

Tiziana Life Sciences to Present at BIO-Europe in Vienna, Highlighting Innovative Immunomodulation Therapy Globe Newswire 7:00 AM

-- September 30, 2025 --

Tiziana Life Sciences Invited to Attend Life Sciences Innovation Forum 2025 in Riyadh, Saudi Arabia Globe Newswire 8:30 AM

-- September 25, 2025 --

Tiziana to Advance TZLS-501 - Its Fully Human IL-6R Monoclonal Antibody Globe Newswire 8:30 AM

-- September 24, 2025 --

Tiziana Life Sciences Announces Poster Presentation on Intranasal Foralumab Clinical Trial at the 41st ECTRIMS Congress Globe Newswire 8:30 AM

-- September 15, 2025 --

Department of Defense Awards Grant to Advance Tiziana Life Sciences Intranasal Anti-CD3 Therapy for Spinal Cord Injury Globe Newswire 8:00 AM

-- September 9, 2025 --

Tiziana Life Sciences Announces Purchase of Shares by Chief Executive Officer Globe Newswire 8:30 AM

-- September 5, 2025 --

Tiziana Life Sciences Announces Purchase of Shares by Chairman Globe Newswire 8:30 AM

-- August 14, 2025 --

Tiziana Life Sciences Doses First Patient in Phase 2a Trial of Intranasal Foralumab for Multiple System Atrophy Globe Newswire 8:30 AM

-- August 11, 2025 --

FDA Approves Tiziana Life Sciences Phase 2 IND for Multiple System Atrophy Globe Newswire 9:00 AM

-- July 21, 2025 --

Tiziana Life Sciences Announces Immunologic Analysis of Nasal Foralumab in Moderate Alzheimer's Patient Globe Newswire 7:00 AM
Market Data Delayed 15 Minutes